Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 14, 2022

Deputy v. Akebia Therapeutics, Inc. et al

Track this case

Case Number:

1:22-cv-01411

Court:

New York Eastern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Ann M Donnelly

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 15, 2022

    Akebia Hit With Investor Suit Over Anemia Drug Disclosure

    Kidney drug company Akebia Therapeutics Inc. is facing a shareholder suit that accuses it of misrepresenting the regulatory approval chances for an anemia therapy it had in the works, which an investor said pushed down trading prices for the company's shares by nearly 75%.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login